GharibH, PapiniE. Thyroid nodules: Clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am, 2007; 36(3):707–735, vi; doi: 10.1016/j.ecl.2007.04.009.36
2.
HegedüsL. Clinical practice. The thyroid nodule. N Engl J Med, 2004; 351(17):1764–1771; doi: 10.1056/NEJMcp031436
3.
DuranteC, CostanteG, LucisanoG, et al.The natural history of benign thyroid nodules. JAMA, 2015; 313(9):926–935; doi: 10.1001/jama.2015.0956
4.
MuC, MingX, TianY, et al.Mapping global epidemiology of thyroid nodules among general population: A systematic review and meta-analysis. Front Oncol, 2022; 12:1029926; doi: 10.3389/fonc.2022.1029926.eCollection2022
5.
BartschDK, DotzenrathC, VorländerC, et al.The StuDoQ/Thyroid Study Group TSS Current Practice of Surgery for Benign Goitre—An analysis of the Prospective DGAV StuDoQ Thyroid Registry. J Clin Med, 2019; 8(4):477; doi: 10.3390/jcm8040477
6.
HauchA, Al-QurayshiZ, FriedlanderP, et al.Association of socioeconomic status, race, and ethnicity with outcomes of patients undergoing thyroid surgery. JAMA Otolaryngol Head Neck Surg, 2014; 140(12):1173–1183; doi: 10.1001/jamaoto.2014.1745
7.
SorensenJR, PrintzT, IwarssonJ, et al.The impact of post-thyroidectomy paresis on quality of life in patients with nodular thyroid disease. Otolaryngol Head Neck Surg, 2019; 161(4):589–597; doi: 10.1177/0194599819855379
8.
BonnemaSJ, HegedüsL. Radioiodine therapy in benign thyroid diseases: Effects, side effects, and factors affecting therapeutic outcome. Endocr Rev, 2012; 33(6):920–980; doi: 10.1210/er.2012-1030
LivraghiT, ParacchiA, FerrariC, et al.Treatment of autonomous thyroid nodules with percutaneous ethanol injection: Preliminary results. Work in progress. Radiology, 1990; 175(3):827–829; doi: 10.1148/radiology.175.3.2188302
11.
GugliemiR, PacellaCM, BianchiniA, et al.Percutaneous ethanol injection treatment in benign thyroid lesions: Role and efficacy. Thyroid, 2004; 14(2):125–131; doi: 10.1089/105072504322880364
12.
BennedbaekFN, KarstrupS, HegedüsL. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol, 1997; 136(3):240–250; doi: 10.1530/eje.0.1360240
13.
VerdeG, PapiniE, PacellaCM, et al.Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf), 1994; 41(6):719–724; doi: 10.1111/j.1365-2265.1994.tb02785.x
14.
BennedbaekFN, HegedüsL. Treatment of recurrent thyroid cysts with ethanol: A randomized double-blind controlled trial. J Clin Endocrinol Metab, 2003; 88(12):5773–5777; doi: 10.1210/jc.2003-031000
BaekJH, KimYS, RhimH, et al.Radiofrequency ablation of benign cold thyroid nodules: Initial clinical experience. Thyroid, 2006; 16(4):361–367; doi: 10.1089/thy.2006.16.361
18.
EsnaultO, FrancB, MenegauxF, et al.High-intensity focused ultrasound ablation of thyroid nodules: First human feasibility study. Thyroid, 2011; 21(9):965–973; doi: 10.1089/thy.2011.0141
19.
FengB, LiangP, ChengZ, et al.Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: Experimental and clinical studies. Eur J Endocrinol, 2012; 166(6):1031–1037.
PapiniE, GuglielmiR, BizzarriG, et al.Treatment of benign cold thyroid nodules: A randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid, 2007; 17(3):229–235; doi: 10.1089/thy.2006.0204
22.
PapiniE, RagoT, GambelungheG, et al.Long-term efficacy of ultrasound -guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab, 2014; 99(10):3653–3659; doi: 10.1210/jc.2014-1826
23.
DeandreaM, SungJY, LimoneP, et al.Efficacy and safety of radiofrequency ablation versus observation for non-functioning benign thyroid nodules: A randomized controlled international collaborative trial. Thyroid, 2015; 25(8):890–896; doi: 10.1089/thy.2015.0133
24.
DuJR, LiWH, QuanCH, et al.Long-term outcome of microwave ablation for benign thyroid nodules. Over 48-month follow-up study. Front Endocrinol (Lausanne), 2022; 13:941137; doi: 10.3389/fendo.2022.941137.eCollection2022
25.
ChoSJ, BaekJH, ChungSR, et al.Long-term results of thermal ablation of benign thyroid nodules: A systematic review and meta-analysis. Endocrinol Metab, 2020; 35(2):339–350; doi: 10.3803/EnM.2020.35.2.339
26.
MonpeyssenH, Ben HamouA, HegedüsL, et al.High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules: A 3-year retrospective multicenter follow-up study. Int J Hyperthermia, 2020; 37(1):1301–1309; doi: 10.1080/02656736.2020.1846795
27.
YueW, WangS, WangB, et al.Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: Safety and imaging follow-up in 222 patients. Eur J Radiol, 2013; 82(1):e11–e16; doi: 10.1016/j.ejrad.2012.07.020
28.
BernardiS, GiudiciF, CesareoR, et al.Five-year results of radiofrequency and laser ablation of benign thyroid nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group. Thyroid, 2020; 30(12):1759–1770; doi: 10.1089/thy.2020.0202
29.
ChungSR, SuhCH, et al.Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: A systematic review and meta-analysis. Int J Hyperthermia, 2017; 33(8):920–930; doi: 10.1080/02656736.2017.1337936
30.
ChenF, TianG, KongD, et al.Radiofrequency ablation for treatment of benign thyroid nodules: A PRISMA-compliant systematic review and meta-analysis of outcomes. Medicine (Baltimore), 2016; 95(34):e4659; doi: 10.1097/MD.0000000000004659
31.
TrimboliP, CastellanaM, SconfienzaLM, et al.Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: A systematic review and meta-analysis. Endocrine, 2020; 67(1):35–43; doi: 10.1007/s12020-019-02019-3
32.
KimJH, BaekJH, LimHK, et al.; Guideline Committee for the Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. 2017 Thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol, 2018; 19(4):632–655; doi: 10.3348/kjr.2018.19.4.632
33.
PapiniE, PacellaCM, SolbiatiLA, et al.Minimally invasive treatments for benign thyroid nodules: A Delphi-based consensus statement from the Italian minimally invasive treatments of the thyroid (MITT) group. Int J Hyperthermia, 2019; 36(1):376–382; doi: 10.1080/02656736.2019.1575482
34.
DobnigH, ZechmannW, HermannM, et al.Radiofrequency ablation of thyroid nodules: “Good Clinical Practice Recommendations” for Austria: An interdisciplinary statement from the following professional associations: Austrian Thyroid Association (ÖSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (ÖGES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH). Wien Med Wochenschr, 2020; 170(1–2):6–14; doi: 10.1007/s10354-019-0682-2
35.
PapiniE, MonpeyssenH, FrasoldatiA, et al.2020 European Thyroid Association Clinical Practice Guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J, 2020; 9(4): 172–185; doi: 10.1159/000508484
36.
OrloffLA, NoelJE, StackBCJr, et al.Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association. Head Neck, 2022; 44(3):633–660; doi: 10.1002/hed.26960
37.
HaEJ, BaekJH, CheY, et al.Radiofrequency ablation of benign thyroid nodules: Recommendations from the Asian Conference on Tumor Ablation Task Force—Secondary Publication. J Med Ultrasound, 2021; 29(2):77–83; doi: 10.4103/JMU.JMU_178_20
38.
ZhangL, ZhouW, ZhouJQ, et al.2022 Expert consensus on the use of laser ablation for papillary thyroid microcarcinoma. Int J Hyperthermia, 2022; 39(1):1254–1263; doi: 10.1080/02656736.2022.2122596
39.
HegedüsL, FrasoldatiA, NegroR, et al.European Thyroid Association Survey on use of minimally invasive techniques for thyroid nodules. Eur Thyroid J, 2020; 9(4):194–204; doi: 10.1159/000506513
40.
ChortiA, BontinisV, TzikosG, et al.Minimally invasive treatments of benign thyroid nodules: A network meta-analysis of short-term outcomes. Thyroid, 2023; 33(8):950–964; doi: 10.1089/thy.2022.0671
41.
PapiniE, CrescenziA, D'AmoreA, et al.Italian Guidelines for the management of non-functioning benign and locally symptomatic thyroid nodules. Endocr Metab Immune Disord Drug Targets, 2023; In Press; doi: 10.2174/1871530323666230201104112
42.
SimJS, BaekJH. Long-term outcomes following thermal ablation of benign thyroid nodules as an alternative to surgery: The importance of controlling regrowth. Endocrinol Metab (Seoul), 2019; 34(2):117–123; doi: 10.3803/EnM.2019.34.2.117
43.
MauriG, PacellaCM, PapiniE, et al.Image-guided thyroid ablation: Proposal for standardization of terminology and reporting criteria. Thyroid, 2019; 29(5):611–618; doi: 10.1089/thy.2018.0604
44.
JinH, FanJ, LiaoK, et al.A propensity scores matching study between ultrasound-guided percutaneous microwave ablation and conventional thyroidectomy for benign thyroid nodules treatment. Int J Hyperthermia, 2018; 35(1):232–238; doi: 10.1080/02656736.2018.1492028
45.
BernardiS, DobrinjaC, CarereA, et al.Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: A telephone survey. Int J Hyperthermia, 2018; 35(1):150–158; doi: 10.1080/02656736.2018.1487590
46.
YueWW, WangSR, LiXL, et al.Quality of Life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: A retrospective cohort study. Sci Rep, 2016; 6:37838; doi: 10.1038/srep37838
47.
WattT, CramonP, HegedüsL, et al.The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab, 2014 Oct;99(10):3708–3717; doi: 10.1210/jc.2014-1322
48.
NordqvistSF, BoesenVB, Rasmussen ÅK, et al. Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO. Endocr Connect, 2021; 10(3):316–324; doi: 10.1530/EC-21-0026
49.
MauriG, HegedusL, BandulaS, et al.European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J, 2021; 10(3):185–197; doi: 10.1159/000516469
50.
HegedüsL, MiyauchiA, TuttleRM. Nonsurgical thermal ablation of thyroid nodules: Not if, but Why, When, and How?. Thyroid, 2020; 30(12):1691–1694; doi: 10.1089/thy.2020.0659
51.
RussG, Ben HamouA, PoiréeS, et al.Learning curve for radiofrequency ablation of benign thyroid nodules. Int J Hyperthermia, 2021; 38(1):55–64; doi: 10.1080/02656736.2021.1871974